Recombinant DNA A<Jvisoiy Committee - 6/9-10/94 
James Economou, University of California, Lx>s Angeles 
Chris Evans, University of Pittsburgh 
Chuck Finn, Genetics Institute, Inc. 
Ohvera Finn, University of Pittsburgh 
Terence Flotte, Johns Hopkins Hospital 
Suzanne Forry-Schaudies, Genetic TTnerapy, Inc. 
Ralph Freedman, MD Anderson Cancer Center 
Joyce Frey, Food and Drug Adminstration 
Lynn Frohnmayer, Mothers of Children with Fanconi Anemia 
Morgan Gale, Hearings-on-the-line 
Diane Gershon, Nature Magazine 
Richard Giles, MD Anderson Cancer Center 
Alan Goldhammer, Biotechnology Industry Organization 
Richard Gregory, Canji, Inc. 
Robert Grossman, Arrow International Marketing, Inc. 
Elie Hanania, MD Anderson Cancer Center 
Helen Heslop, St. Jude Childrens Research Hospital 
Frankie Holmes, MD Anderson Cancer Center 
David Holzman, BioWorld 
Joseph Hughes, Quality Biotech 
Edie Irvine, Genetic Therapy, Inc. 
Jeffrey Isner, St. Elizabeths Medical Center 
Bobbi Kamil, Cable in the Classroom 
Michael Kanaley, The Novus Group 
Karilyn Kelson, Mothers of Children with Fanconi Anemia 
Martin Korbling, MD Anderson Cancer Center 
Toshi Kotani, Genetic Therapy, Inc. 
Steven Kradjian, Vical, Inc. 
Gary Kurtzman, Avigen, Inc. 
A1 Kuta, Food and Drug Administration 
Albert Lobuglio, University of Alabama 
Michael Lotze, University of Pittsburgh 
Bill Macaulay, University of Pittsburgh 
Tamie Malaska, Targeted Genetics Corporation 
Dan Maneval, Canji, Inc. 
Tony Marcel, TMC Development 
Eliot Marshall, Science Magazine 
John Marshall, Magenta Corporation 
Alan McClelland, Genetic Therapy, Inc. 
Ger 2 ird McGarrity, Genetic Therapy, Inc. 
Andra Miller, Food and Drug Administration 
Grant Mitchell, St. Justin Hospital 
Micheal Nash, MD Anderson Cancer Center 
Philip Noguchi, Food and Drug Administration 
Sheryl Osborne, Viagene, Inc. 
Jeffrey Ostrove, Magenta Corporation 
Recombinant DNA Research, Volume 19 
[311] 
